DPM 6/7 Patient Monitor Manufactured in China for : Mindray DS USA, Inc. 800 MacArthur Blvd. ...
FDA Device Recall #Z-0513-2013 - Class II, August 11, 2010
Recall Summary
| Recall Number | Z-0513-2013 |
| Classification | Class II - Moderate risk |
| Date Initiated | August 11, 2010 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mindray DS USA, Inc. d.b.a. Mindray North America |
| Location | Mahwah, NJ |
| Product Type | Devices |
| Quantity | 124 units |
Product Description
DPM 6/7 Patient Monitor Manufactured in China for : Mindray DS USA, Inc. 800 MacArthur Blvd. Mahwah, NJ 07430 USA. Intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters including ECG (3-lead or 5-lead or 12-lead selectable). arrhythmia detection, ST Segment analysis, heart rate (HR) , respiration rate (RESP), temperature (TEMP), pulse oxygen saturation (SpO2), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure (IBP), carbon dioxide (CO2), anesthetic gas (AG),impedance cardiograph (ICG), bispectral index (BIS), cardiac output (C.O.) and respiration mechanics (RM).
Reason for Recall
There is an issue with the DPM 6 and DPM 7 monitors where the following features may be unavailable : Full Disclosure, Drug, Hemodynamic Calculations, Renal Calculations, Oxygenation Calculations, and Ventilation Calculations.
Distribution Pattern
Nationwide Distribution-USA (nationwide) including the states of WA, IL, FL, MN, SC, NV, MI, TN, PA, LA, NE, TX, and IA.
Lot / Code Information
K092449 DPM 6- p/n 6802F-PA00001 DPM 7 - p/n 6800F-PA00001
Other Recalls from Mindray DS USA, Inc. d.b.a. Mindray N...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0977-2013 | Class II | BS-200 Chemistry Analyzer Designed for clini... | Nov 28, 2012 |
| Z-0798-2013 | Class II | Mindray DS USA, Inc., DPM Central Monitoring Sy... | Nov 28, 2012 |
| Z-0528-2013 | Class II | Mindray V12 Size: 320 mm X 320 mm X 450 mm N.W.... | Sep 24, 2012 |
| Z-0742-2013 | Class II | Mindray DPM5 Monitor, a vital signs monitor us... | Sep 5, 2012 |
| Z-0291-2013 | Class I | Mindray A5 Anesthesia Delivery System Manufac... | Aug 13, 2012 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.